Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATRI
3476
DELISTED
Atrion Corp
ATRI
| $3.42M | ﹤0.01% |
4,014
-302
| -7% | -$267K |
|
3477
Cyclerion Therapeutics
CYCN
$17.7M
| $3.42M | ﹤0.01% |
+14,922
| New | +$4.22M |
|
3478
PUT
ProShares UltraPro Short S&P 500
SPXU
$380M
| $3.42M | ﹤0.01% |
1,228
-396
| -24% | -$1.18M |
|
3479
PUT
Fox Class A
FOXA
$29B
| $3.42M | ﹤0.01% |
93,200
+62,000
| +199% | +$2.28M |
|
3480
Lexicon Pharmaceuticals
LXRX
$1.03B
| $3.41M | ﹤0.01% |
542,747
+231,120
| +74% | +$1.38M |
|
3481
Invesco DB US Dollar Index Bullish Fund
UUP
$413M
| $3.41M | ﹤0.01% |
131,329
-103,731
| -44% | -$2.71M |
|
3482
CALL
State Street Communication Services Select Sector SPDR ETF
XLC
$22.9B
| $3.41M | ﹤0.01% |
69,300
+18,800
| +37% | +$914K |
|
|
PVG
3483
CALL
DELISTED
PRETIUM RESOURCES INC.
PVG
| $3.41M | ﹤0.01% |
340,800
-106,600
| -24% | -$905K |
|
3484
PUT
National Health Investors
NHI
$3.58B
| $3.41M | ﹤0.01% |
43,700
-11,600
| -21% | -$901K |
|
|
AVTA
3485
DELISTED
Avantax, Inc. Common Stock
AVTA
| $3.4M | ﹤0.01% |
+111,859
| New | +$3.68M |
|
|
RETA
3486
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.4M | ﹤0.01% |
36,000
+12,500
| +53% | +$1.08M |
|
3487
Addus HomeCare
ADUS
$2.17B
| $3.39M | ﹤0.01% |
45,264
+9,725
| +27% | +$672K |
|
3488
Synaptics
SYNA
$4.25B
| $3.39M | ﹤0.01% |
116,300
+94,078
| +423% | +$3.07M |
|
|
LCI
3489
DELISTED
Lannett Company, Inc.
LCI
| $3.39M | ﹤0.01% |
139,759
-29,453
| -17% | -$778K |
|
3490
Interactive Brokers
IBKR
$41.7B
| $3.39M | ﹤0.01% |
249,924
+1,148
| +0.5% | +$15.6K |
|
|
ZUO
3491
DELISTED
Zuora, Inc.
ZUO
| $3.38M | ﹤0.01% |
220,938
+46,912
| +27% | +$889K |
|
3492
Newmark Group
NMRK
$2.76B
| $3.38M | ﹤0.01% |
376,579
-455,202
| -55% | -$3.83M |
|
3493
CALL
Royal Bank of Canada
RY
$301B
| $3.38M | ﹤0.01% |
42,600
+4,000
| +10% | +$313K |
|
|
TCDA
3494
DELISTED
Tricida, Inc. Common Stock
TCDA
| $3.38M | ﹤0.01% |
+85,700
| New | +$3.01M |
|
|
AXON
3495
Axon Enterprise
AXON
$49.8B
| $3.38M | ﹤0.01% |
52,649
+41,815
| +386% | +$2.73M |
|
|
RUBY
3496
DELISTED
Rubius Therapeutics, Inc
RUBY
| $3.38M | ﹤0.01% |
+214,963
| New | +$3.47M |
|
3497
Dianthus Therapeutics
DNTH
$6.49B
| $3.38M | ﹤0.01% |
14,317
+3,428
| +31% | +$848K |
|
|
ARCH
3498
DELISTED
Arch Resources, Inc.
ARCH
| $3.38M | ﹤0.01% |
35,861
-123,681
| -78% | -$11.3M |
|
3499
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
| $3.37M | ﹤0.01% |
113,337
+43,815
| +63% | +$1.27M |
|
3500
Nordic American Tanker
NAT
$1.42B
| $3.36M | ﹤0.01% |
1,437,242
+396,660
| +38% | +$854K |
|
Similar funds
Citadel Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
- Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
- Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.